T2 Biosystems, Inc.
NASDAQ:TTOO
Overview | Financials
Company Name | T2 Biosystems, Inc. |
Symbol | TTOO |
Currency | USD |
Price | 0.345 |
Market Cap | 7,259,835 |
Dividend Yield | 0% |
52-week-range | 0.31 - 8.38 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. John J. Sperzel III, B.Sc. |
Website | https://www.t2biosystems.com |
An error occurred while fetching data.
About T2 Biosystems, Inc.
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD